Endometrial cancer screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Endometrial Cancer Screening== | ==Endometrial Cancer Screening== | ||
There is insufficient evidence to recommend routine screening for endometrial cancer.<ref name="endometrialcancerscreening">{{Cite web | title =Endometrial Cancer Screening| url = http://www.cancer.gov/types/uterine/patient/endometrial-screening-pdq#section/_13}}</ref> | There is insufficient evidence to recommend routine screening for endometrial cancer.<ref name="endometrialcancerscreening">{{Cite web | title =Endometrial Cancer Screening| url = http://www.cancer.gov/types/uterine/patient/endometrial-screening-pdq#section/_13}}</ref> | ||
Women with Lynch syndrome have a risk of developing endometrial cancer up to 50% higher than the general population. | |||
* Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member). | |||
==References== | ==References== | ||
Revision as of 14:06, 29 November 2018
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer screening On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer screening |
|
Risk calculators and risk factors for Endometrial cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for endometrial cancer.[1]
Endometrial Cancer Screening
There is insufficient evidence to recommend routine screening for endometrial cancer.[1]
Women with Lynch syndrome have a risk of developing endometrial cancer up to 50% higher than the general population.
- Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member).